Structure Therapeutics Inc. (GPCR) income statement
GPCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$17.36−0.81 (-4.46%)
Close on Nov 18, 2026Market cap $1.24BP/E –Yield –
Structure Therapeutics Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -11.9%
Financial strength
- Current ratio
- 20.75
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 412.4%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.91
- Dividend yield
- –
See a number that looks wrong?